Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: A case of naloxone-induced withdrawal

被引:41
作者
CulpepperMorgan, JA
Kreek, MJ
机构
[1] Biol. of Addictive Dis. Laboratory, Rockefeller University, New York, NY
[2] c/o the Biol. of Addictive Dis. Lab., Rockefeller University, 1230 York Ave, New York
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1997年 / 46卷 / 02期
关键词
D O I
10.1016/S0026-0495(97)90289-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A case of opioid withdrawal precipitated in an opioid-dependent person by low plasma levels of naloxone is presented. In this patient, changes were observed in the hypothalamic-pituitary-adrenal (HPA) axis that preceded the clinical symptoms and adrenergic signs of withdrawal. Plasma naloxone levels were strongly correlated with plasma cortisol levels (P < .0001, R(2) = .73, r = .85). In addition, these neuroendocrine changes persisted after adrenergic changes and clinical symptoms had been ameliorated by administration of a short-acting opioid agonist. It is suggested that the HPA axis is a more sensitive indicator of opioid withdrawal than the adrenergic system. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 32 条
  • [1] QUANTITATIVE AND PHARMACOKINETIC ANALYSIS OF NALOXONE IN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION AND SOLID-PHASE EXTRACTION
    ALBECK, H
    WOODFIELD, S
    KREEK, MJ
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 488 (02): : 435 - 445
  • [2] Andrews HL, 1944, J PHARMACOL EXP THER, V81, P288
  • [3] [Anonymous], P 4 NAT C METH TREAT
  • [4] COHEN MR, 1983, ARCH GEN PSYCHIAT, V40, P613
  • [5] TREATMENT OF OPIOID-INDUCED CONSTIPATION WITH ORAL NALOXONE - A PILOT-STUDY
    CULPEPPERMORGAN, JA
    INTURRISI, CE
    PORTENOY, RK
    FOLEY, K
    HOUDE, RW
    MARSH, F
    KREEK, MJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 90 - 95
  • [6] USE OF NALOXONE IN THE ASSESSMENT OF OPIATE DEPENDENCE
    FUDALA, PJ
    BERKOW, LC
    FRALICH, JL
    JOHNSON, RE
    [J]. LIFE SCIENCES, 1991, 49 (24) : 1809 - 1814
  • [7] RATIONALE FOR OPIATE WITHDRAWAL SYMPTOMATOLOGY
    GOLD, MS
    KLEBER, HD
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1979, 4 (05) : 419 - 424
  • [8] OPIATE WITHDRAWAL USING CLONIDINE - SAFE, EFFECTIVE, AND RAPID NON-OPIATE TREATMENT
    GOLD, MS
    POTTASH, AC
    SWEENEY, DR
    KLEBER, HD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (04): : 343 - 346
  • [9] NALOXONE RADIOIMMUNOASSAY - AN IMPROVED ANTI-SERUM
    HAHN, EF
    LAHITA, R
    KREEK, MJ
    DUMA, C
    INTURRISI, CE
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (12) : 833 - 836
  • [10] HEISHMAN SJ, 1989, J PHARMACOL EXP THER, V248, P127